2.56
price down icon6.23%   -0.17
 
loading

Inmune Bio Inc Aktie (INMB) Neueste Nachrichten

pulisher
09:43 AM

What are the technical indicators suggesting about INmune Bio Inc.Build wealth with long-term growth strategies - jammulinksnews.com

09:43 AM
pulisher
07:59 AM

How does INmune Bio Inc. generate profit in a changing economyConsistent triple-digit returns - jammulinksnews.com

07:59 AM
pulisher
04:46 AM

What institutional investors are buying INmune Bio Inc. stockBuild wealth faster with disciplined trading - jammulinksnews.com

04:46 AM
pulisher
04:07 AM

Is INmune Bio Inc. stock overvalued or undervaluedAchieve consistent profits with proven methods - jammulinksnews.com

04:07 AM
pulisher
03:52 AM

What analysts say about INmune Bio Inc. stockTremendous gains - jammulinksnews.com

03:52 AM
pulisher
02:46 AM

Is INmune Bio Inc. a growth stock or a value stockBuild a diversified portfolio for steady growth - jammulinksnews.com

02:46 AM
pulisher
02:25 AM

What are analysts’ price targets for INmune Bio Inc. in the next 12 monthsExplosive wealth accumulation - jammulinksnews.com

02:25 AM
pulisher
02:08 AM

How does INmune Bio Inc. compare to its industry peersGet real-time alerts on high-potential stocks - jammulinksnews.com

02:08 AM
pulisher
01:25 AM

What makes INmune Bio Inc. stock price move sharplyUnlock powerful trading alerts for success - jammulinksnews.com

01:25 AM
pulisher
Aug 02, 2025

What is INmune Bio Inc. company’s growth strategyAccelerated wealth building - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

What drives INmune Bio Inc. stock priceDouble-digit growth - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 01, 2025

Is it the right time to buy INmune Bio Inc. stockFinancial News Planner Backed By Experts - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

INmune Bio Inc. May Be Forming Higher Low — Chartwatchers AlertReal Trader Watchlist of Hot Stocks Released - metal.it

Aug 01, 2025
pulisher
Aug 01, 2025

Price Channel Expanding on INmune Bio Inc.’s ChartOversold Bounce Stock Play Ideas Gain Attention - metal.it

Aug 01, 2025
pulisher
Jul 31, 2025

Inmune Bio Inc. shares fall 1.83% after-hours as the company prepares to report Q2 2025 financial results. - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

INmune Bio Inc. to Host Conference Call on August 7, 2025 for Q2 Results and Corporate Update - Quiver Quantitative

Jul 31, 2025
pulisher
Jul 31, 2025

INmune Bio Announces Q1 Earnings Call on August 7th, 2025 at 4:30 PM EDT. - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th - The Manila Times

Jul 31, 2025
pulisher
Jul 31, 2025

INmune Bio to Present Q2 2025 Financial Results and Key Clinical-Stage Updates on August 7 - Stock Titan

Jul 31, 2025
pulisher
Jul 31, 2025

When is INmune Bio Inc. stock expected to show significant growthReal Time Guidance For 2025 - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

Inmune Bio shares fall 2.53% premarket after announcing a video detailing MINDFuL trial findings. - AInvest

Jul 30, 2025
pulisher
Jul 29, 2025

Inmune Bio Inc. shares fall 4.75% after-hours following the release of a video detailing the MINDFuL trial. - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

INmune Bio Releases Video on Alzheimer’s Trial Results - TipRanks

Jul 29, 2025
pulisher
Jul 29, 2025

INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference - The Manila Times

Jul 29, 2025
pulisher
Jul 29, 2025

INmune Bio To Share New Alzheimer's Trial Results On YouTube After Major Conference Reveal - 富途牛牛

Jul 29, 2025
pulisher
Jul 29, 2025

INmune Bio to Publish Video on MINDFuL Trial Findings for XPro™ Treatment at Alzheimer's Association International Conference. - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Breakthrough in Alzheimer's Treatment: Phase 2 Trial Reveals XPro Drug's Impact on Cognitive Decline - Stock Titan

Jul 29, 2025
pulisher
Jul 28, 2025

How INmune Bio Inc. stock performs during market volatilityROI Driven Equity Selection With Safety Emphasized - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Trend Reversal Possible in INmune Bio Inc. Charts IndicateSwing Trade Entry With Volume Triggers Released - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Is INmune Bio Inc. Stock a Good Fit for Conservative InvestorsDaily Volume Spike Trading Signals Detected - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Alzheimer’s Breakthrough: INmune Bio’s XPro Trial Shows Promise in Subpopulation - StocksToTrade

Jul 28, 2025
pulisher
Jul 28, 2025

INmune Bio Stock Soars 19.56% on Clinical Trial Success - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge? - Benzinga

Jul 28, 2025
pulisher
Jul 27, 2025

How many analysts rate INmune Bio Inc. as a “Buy”Achieve breakthrough profits with expert advice - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

New Product Launches: Will They Boost INmune Bio Inc. Stock in 2025Best Stocks for Capital Safety - metal.it

Jul 27, 2025
pulisher
Jul 26, 2025

Inmune Bio Reveals Promising XPro™ Trial Results - The Globe and Mail

Jul 26, 2025
pulisher
Jul 26, 2025

Why INmune Bio Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

Is INmune Bio Inc. a good long term investmentOutstanding capital growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

INmune Bio Shares Plunge After Alzheimer's Trial Misses Target - Finimize

Jul 25, 2025
pulisher
Jul 25, 2025

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at - GuruFocus

Jul 25, 2025
pulisher
Jul 24, 2025

INmune Bio Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - PrintWeekIndia

Jul 24, 2025
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Kapitalisierung:     |  Volumen (24h):